DK164484C - Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen - Google Patents

Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen

Info

Publication number
DK164484C
DK164484C DK136385A DK136385A DK164484C DK 164484 C DK164484 C DK 164484C DK 136385 A DK136385 A DK 136385A DK 136385 A DK136385 A DK 136385A DK 164484 C DK164484 C DK 164484C
Authority
DK
Denmark
Prior art keywords
preparation
surfactive
ionogen
anion
mixtures
Prior art date
Application number
DK136385A
Other languages
Danish (da)
English (en)
Other versions
DK164484B (da
DK136385A (da
DK136385D0 (da
Inventor
Norman Grant Gaylord
Joseph Martin Schor
Original Assignee
Forest Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories filed Critical Forest Laboratories
Publication of DK136385D0 publication Critical patent/DK136385D0/da
Publication of DK136385A publication Critical patent/DK136385A/da
Publication of DK164484B publication Critical patent/DK164484B/da
Application granted granted Critical
Publication of DK164484C publication Critical patent/DK164484C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
DK136385A 1984-03-26 1985-03-26 Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen DK164484C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/592,570 US4795327A (en) 1984-03-26 1984-03-26 Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US59257084 1984-03-26

Publications (4)

Publication Number Publication Date
DK136385D0 DK136385D0 (da) 1985-03-26
DK136385A DK136385A (da) 1985-09-27
DK164484B DK164484B (da) 1992-07-06
DK164484C true DK164484C (da) 1992-11-16

Family

ID=24371220

Family Applications (1)

Application Number Title Priority Date Filing Date
DK136385A DK164484C (da) 1984-03-26 1985-03-26 Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen

Country Status (9)

Country Link
US (1) US4795327A (es)
EP (1) EP0157695B1 (es)
JP (1) JPS60218329A (es)
CA (1) CA1240925A (es)
DE (1) DE3583694D1 (es)
DK (1) DK164484C (es)
ES (1) ES8607009A1 (es)
PL (1) PL144347B1 (es)
YU (1) YU45915B (es)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585246A1 (fr) * 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
EP0297866A3 (en) * 1987-07-01 1989-12-13 The Boots Company PLC Therapeutic agents
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
HU201869B (en) * 1988-12-30 1991-01-28 Egyt Gyogyszervegyeszeti Gyar Process for producing microcapsules of quick dissolving active component
US5437872A (en) * 1989-08-25 1995-08-01 Bioglan Laboratories Ltd. Pharmaceutical compositions and a device for administering the same
FR2656525A1 (fr) * 1989-12-29 1991-07-05 Delalande Sa Formes d'administration de medicament a liberation controlee et leur procede de fabrication.
SE9003713L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande dietfiberkomposition
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
SE9003904D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Method for the manufacture of a pharmaceutical dosage form
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
AU8293498A (en) 1997-07-02 1999-01-25 Euro-Celtique S.A. Stabilized sustained release tramadol formulations
FR2766707A1 (fr) * 1997-07-30 1999-02-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethyl-cellulose et/ou de l'ethylcellulose a titre d'agents desintegrants, et procede d'obtention
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
CA2354057C (en) 1998-12-11 2009-02-10 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
EP1551372B8 (en) * 2002-09-20 2018-08-01 Alpharma Pharmaceuticals LLC Sequestering subunit and related compositions and methods
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2526932B1 (en) 2006-06-19 2017-06-07 Alpharma Pharmaceuticals LLC Pharmaceutical composition
WO2008063301A2 (en) * 2006-10-11 2008-05-29 Alpharma, Inc. Pharmaceutical compositions
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
MX2009013384A (es) * 2007-06-08 2010-01-25 Addrenex Pharmaceuticals Inc Formulacion de liberacion extendida, y metodo para tratar disregulacion adrenergica.
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
AU2008338442A1 (en) * 2007-12-17 2009-06-25 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US9464227B2 (en) * 2014-03-24 2016-10-11 Lamberti Spa Moisturizing agents
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7048639B2 (ja) * 2017-04-13 2022-04-05 ザ プロクター アンド ギャンブル カンパニー 離散粒子及び水性ベース組成物を含む製品組成物の調製方法
AU2019303725A1 (en) * 2018-07-17 2022-02-03 Ferromedica Pty Ltd Ferrous sulphate formulations and uses thereof
US11931441B2 (en) 2018-10-10 2024-03-19 The Procter & Gamble Company Personal care product customized by discrete particles and method of apply thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
EP0157695A2 (en) 1985-10-09
DK164484B (da) 1992-07-06
PL144347B1 (en) 1988-05-31
US4795327A (en) 1989-01-03
YU45915B (sh) 1992-09-07
PL252614A1 (en) 1985-12-17
YU49585A (en) 1990-12-31
ES541503A0 (es) 1986-05-16
CA1240925A (en) 1988-08-23
JPS60218329A (ja) 1985-11-01
EP0157695B1 (en) 1991-08-07
DK136385A (da) 1985-09-27
DK136385D0 (da) 1985-03-26
EP0157695A3 (en) 1987-05-13
ES8607009A1 (es) 1986-05-16
DE3583694D1 (de) 1991-09-12

Similar Documents

Publication Publication Date Title
DK164484C (da) Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen
DK546886A (da) Farmaceutisk praeparat til reguleret frigoerelse af aktive stoffer
NO904446L (no) Additivkonsentrat for polymere materialer, samt fremstilling av additivkonsentratet.
NO865202D0 (no) Tyggbart materiale for utlevering av aktive substanser.
IT8720650A0 (it) Derivati dell'etere immidazochinolinilico ad azione farmaceutica e procedimento per laloro preparazione.
NO851881L (no) Innretning for avgivelse av flyktige, virksomme materialer.
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK490482A (da) Derivater af cis,endo-2-azabicyclo-(3.3.0)-octan-3-carboxylsyren, fremgangsmaade til deres fremstilling, midler med indhold deraf samt deres anvendelse
NL187022C (nl) Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
FI851337L (fi) N-aryl-n-(4-piperidinyl)-amider och dessa innehaollande farmaceutiska kompositioner och deras anvaendning.
DK164904C (da) Hydantoinderivater, fremgangsmaade til fremstilling deraf, herbicidt praeparat indeholdende forbindelserne samt anvendelse af forbindelserne ved bekaempelse af ukrudt
DK160969C (da) Fremgangsmaade til fremstilling af toerre, fritflydende pulvere af let oxiderbare stoffer
DK157168C (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid
NO860867L (no) Materiale som er anvendelig som farmasoeylisk eksipient, samt fremgangsmaate for fremstilling av et slikt.
IT8422142A0 (it) Procedimento di preparazione. cefem composti ad azione farmaceutica e relativo
DK147386D0 (da) Derivater af methylen-bisphosphonsyre, fremgangsmaade til fremstillingaf samme samt farmaceutisk sammensaetning
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
DK159652C (da) Cholecalciferolderivater, disse derivater til brug som terapeutisk aktive substanser, fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat baseret paa disse cholecalciferolderivater
IL63424A (en) 5-substituted oxazolidine-2,4-diones,their preparation and pharmaceutical compositions comprising them
ES508483A0 (es) "perfeccionamientos en los dosificadores y alimentadores de material en polvo en moldes para la fabricacion de baldosas de cemento y similares".
DK476685A (da) Alfa-aminoalkyl-alfa-alkylphenylacetonitrilderivater, fremgangsmaade til fremstilling af samme samt farmaceutisk komposition med indhold heraf
DK444589A (da) Mikrobiologisk fremgangsmaade til fremstilling af agrarkemisk anvendelige stoffer
ES2018656B3 (es) Nuevos derivados del acido 16,17-acetal sustituido, procedimiento de preparacion del mismo y preparaciones farmaceuticas que los contienen.
DK269986D0 (da) Fremgangsmaade til foroegelse af den transdermale afgivelse af laegemidler samt praeparat til transdermal administrering

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK